Nifty
Sensex
:
:
11681.65
39716.82
-47.95 (-0.41%)
-205.64 (-0.52%)

Pharmaceuticals & Drugs - Global

Rating :
71/99

BSE: 524742 | NSE: CAPLIPOINT

514.20
28-Oct-2020
  • Open
  • High
  • Low
  • Previous Close
  •  514.00
  •  524.00
  •  512.00
  •  517.95
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  61498
  •  317.99
  •  686.00
  •  176.20

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 3,887.66
  • 17.73
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 3,700.71
  • 0.49%
  • 4.23

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 69.03%
  • 1.31%
  • 22.15%
  • FII
  • DII
  • Others
  • 2.25%
  • 0.31%
  • 4.95%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 29.31
  • 16.94

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 32.37
  • 5.96

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 36.26
  • 14.09

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 20.62
  • 26.46
  • 18.59

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 9.81
  • 10.79
  • 7.28

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 16.11
  • 18.47
  • 13.83

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Sep 19
Sep 18
Var%
Net Sales
240.08
192.55
24.68%
215.23
187.34
14.89%
228.21
159.03
43.50%
227.20
155.86
45.77%
Expenses
168.48
125.17
34.60%
161.43
122.58
31.69%
160.45
101.27
58.44%
156.09
100.08
55.97%
EBITDA
71.60
67.38
6.26%
53.80
64.76
-16.92%
67.77
57.76
17.33%
71.12
55.78
27.50%
EBIDTM
29.82%
34.99%
14.01%
34.57%
29.69%
36.32%
31.30%
35.79%
Other Income
6.49
4.47
45.19%
19.63
2.67
635.21%
10.34
7.74
33.59%
6.89
7.01
-1.71%
Interest
0.51
0.01
5,000.00%
0.17
0.01
1,600.00%
0.06
0.02
200.00%
0.08
0.02
300.00%
Depreciation
8.96
7.39
21.24%
8.40
6.72
25.00%
8.43
5.67
48.68%
7.40
5.58
32.62%
PBT
68.62
64.45
6.47%
64.86
60.69
6.87%
69.62
59.81
16.40%
70.53
57.20
23.30%
Tax
14.07
14.38
-2.16%
16.01
10.84
47.69%
10.73
14.00
-23.36%
13.25
13.70
-3.28%
PAT
54.55
50.07
8.95%
48.86
49.86
-2.01%
58.88
45.81
28.53%
57.27
43.50
31.66%
PATM
22.72%
26.00%
7.11%
26.61%
25.80%
28.80%
25.21%
27.91%
EPS
7.22
6.62
9.06%
6.46
6.59
-1.97%
7.79
6.06
28.55%
7.58
5.75
31.83%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Jun 15
Jun 14
Jun 13
Jun 12
Jun 11
Net Sales
910.72
863.20
648.69
539.84
401.65
238.72
251.77
173.09
127.03
107.22
80.78
Net Sales Growth
31.08%
33.07%
20.16%
34.41%
68.25%
-5.18%
45.46%
36.26%
18.48%
32.73%
 
Cost Of Goods Sold
4,969.44
413.16
288.78
238.18
184.93
121.16
135.62
102.58
84.45
77.36
60.88
Gross Profit
-4,058.72
450.04
359.91
301.66
216.72
117.56
116.15
70.50
42.58
29.85
19.89
GP Margin
-445.66%
52.14%
55.48%
55.88%
53.96%
49.25%
46.13%
40.73%
33.52%
27.84%
24.62%
Total Expenditure
646.45
602.27
416.84
344.52
276.84
174.51
192.06
136.90
104.68
96.06
71.58
Power & Fuel Cost
-
14.81
13.76
10.98
9.91
7.56
8.61
3.07
1.12
0.84
0.68
% Of Sales
-
1.72%
2.12%
2.03%
2.47%
3.17%
3.42%
1.77%
0.88%
0.78%
0.84%
Employee Cost
-
67.15
45.58
37.61
29.71
17.92
18.24
12.63
7.69
6.28
4.14
% Of Sales
-
7.78%
7.03%
6.97%
7.40%
7.51%
7.24%
7.30%
6.05%
5.86%
5.13%
Manufacturing Exp.
-
68.23
43.49
37.11
28.56
14.33
16.04
7.42
3.07
1.63
1.54
% Of Sales
-
7.90%
6.70%
6.87%
7.11%
6.00%
6.37%
4.29%
2.42%
1.52%
1.91%
General & Admin Exp.
-
25.50
20.82
12.27
13.78
8.15
7.97
6.54
4.67
3.58
3.00
% Of Sales
-
2.95%
3.21%
2.27%
3.43%
3.41%
3.17%
3.78%
3.68%
3.34%
3.71%
Selling & Distn. Exp.
-
9.95
2.08
5.92
9.41
2.29
2.85
1.46
1.02
0.91
0.67
% Of Sales
-
1.15%
0.32%
1.10%
2.34%
0.96%
1.13%
0.84%
0.80%
0.85%
0.83%
Miscellaneous Exp.
-
3.47
2.33
2.45
0.55
3.10
2.72
3.19
2.66
5.44
0.67
% Of Sales
-
0.40%
0.36%
0.45%
0.14%
1.30%
1.08%
1.84%
2.09%
5.07%
0.82%
EBITDA
264.29
260.93
231.85
195.32
124.81
64.21
59.71
36.19
22.35
11.16
9.20
EBITDA Margin
29.02%
30.23%
35.74%
36.18%
31.07%
26.90%
23.72%
20.91%
17.59%
10.41%
11.39%
Other Income
43.35
41.33
19.03
12.67
9.96
3.66
3.03
3.72
2.10
2.51
2.55
Interest
0.82
1.18
0.58
0.61
0.52
0.34
0.97
0.68
0.77
1.26
1.20
Depreciation
33.19
31.62
23.43
19.00
13.30
7.48
8.38
3.54
1.54
1.24
2.32
PBT
273.63
269.46
226.88
188.38
120.95
60.05
53.39
35.69
22.14
11.17
8.22
Tax
54.06
54.38
50.32
43.74
25.44
14.28
12.26
9.76
8.12
3.14
1.91
Tax Rate
19.76%
20.18%
22.18%
23.22%
21.03%
23.78%
22.96%
27.35%
36.68%
28.11%
23.24%
PAT
219.56
215.00
176.56
144.78
95.61
45.77
41.04
25.85
13.98
8.01
6.28
PAT before Minority Interest
219.27
215.08
176.56
144.63
95.50
45.77
41.13
25.93
14.02
8.03
6.31
Minority Interest
-0.29
-0.08
0.00
0.15
0.11
0.00
-0.09
-0.08
-0.04
-0.02
-0.03
PAT Margin
24.11%
24.91%
27.22%
26.82%
23.80%
19.17%
16.30%
14.93%
11.01%
7.47%
7.77%
PAT Growth
16.02%
21.77%
21.95%
51.43%
108.89%
11.53%
58.76%
84.91%
74.53%
27.55%
 
EPS
29.04
28.44
23.35
19.15
12.65
6.05
5.43
3.42
1.85
1.06
0.83

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Jun 15
Jun 14
Jun 13
Jun 12
Jun 11
Shareholder's Funds
947.91
632.91
363.83
224.76
128.14
93.19
61.74
43.14
33.58
29.08
Share Capital
89.71
51.05
15.12
15.12
15.11
15.11
15.11
15.11
15.11
15.11
Total Reserves
848.76
575.01
345.42
209.56
111.40
78.08
46.63
28.03
18.47
13.97
Non-Current Liabilities
24.86
23.42
27.86
19.90
13.69
10.39
10.42
8.66
4.29
1.82
Secured Loans
0.02
0.29
0.32
0.48
0.73
0.88
2.07
3.48
1.55
0.08
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
5.23
0.13
0.00
0.40
1.63
0.82
0.81
0.38
0.27
0.20
Current Liabilities
144.32
86.11
108.67
113.36
125.04
124.97
107.58
83.01
69.20
40.44
Trade Payables
64.14
60.47
94.23
78.60
55.71
41.56
31.50
25.64
21.26
17.06
Other Current Liabilities
79.28
24.20
13.86
33.09
60.39
72.11
66.42
50.85
38.33
10.71
Short Term Borrowings
0.00
0.00
0.00
0.00
0.00
0.05
0.05
0.05
5.20
9.46
Short Term Provisions
0.91
1.44
0.58
1.67
8.94
11.25
9.60
6.47
4.41
3.22
Total Liabilities
1,125.75
742.52
500.45
358.38
267.14
228.82
179.92
134.90
107.12
71.37
Net Block
272.50
226.84
169.48
151.83
144.23
113.13
102.24
32.71
27.54
24.95
Gross Block
354.79
271.51
231.79
195.15
180.76
142.71
123.06
50.06
43.36
39.53
Accumulated Depreciation
82.29
44.67
62.31
43.31
36.53
29.58
20.82
17.36
15.82
14.58
Non Current Assets
303.23
248.83
196.34
179.16
148.61
146.95
131.30
96.21
53.41
30.12
Capital Work in Progress
20.12
9.70
15.29
3.42
0.23
30.63
24.54
48.98
12.79
0.17
Non Current Investment
0.56
0.33
0.33
13.24
0.44
0.45
0.44
1.19
1.14
1.15
Long Term Loans & Adv.
10.05
11.95
11.23
10.67
3.71
2.75
3.67
10.83
11.94
3.85
Other Non Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Current Assets
822.53
493.69
304.11
179.22
118.53
81.87
48.61
38.70
53.71
41.25
Current Investments
60.23
69.62
46.34
4.20
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
238.23
37.45
28.46
22.29
18.81
13.66
9.79
10.42
6.38
5.50
Sundry Debtors
228.96
159.81
125.88
33.02
7.95
5.66
0.09
0.86
7.28
8.33
Cash & Bank
223.43
152.99
79.28
93.07
68.10
45.37
26.82
16.84
31.80
21.62
Other Current Assets
71.68
9.22
6.88
7.32
23.67
17.18
11.90
10.57
8.25
5.80
Short Term Loans & Adv.
56.81
64.61
17.28
19.31
12.58
11.08
8.16
5.61
4.50
3.44
Net Current Assets
678.21
407.58
195.44
65.86
-6.51
-43.10
-58.97
-44.31
-15.49
0.81
Total Assets
1,125.76
742.52
500.45
358.38
267.14
228.82
179.91
134.91
107.12
71.37

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Jun 15
Jun 14
Jun 13
Jun 12
Jun 11
Cash From Operating Activity
44.68
83.42
66.49
67.61
42.40
49.88
59.83
31.95
27.92
14.25
PBT
269.46
226.88
188.38
120.95
60.05
53.39
35.69
22.14
11.17
8.22
Adjustment
7.09
19.12
14.84
8.61
3.87
6.21
2.14
-0.21
-0.25
2.06
Changes in Working Capital
-177.11
-120.06
-100.38
-38.39
-5.13
1.96
29.32
15.81
18.89
4.49
Cash after chg. in Working capital
99.44
125.94
102.84
91.16
58.78
61.56
67.15
37.75
29.81
14.77
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-54.76
-42.51
-36.35
-23.55
-16.38
-11.67
-7.32
-5.80
-1.89
-0.52
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-54.50
-100.46
-69.02
-36.11
-5.72
-22.66
-43.89
-45.44
-16.44
-6.90
Net Fixed Assets
-43.65
58.45
-48.43
-19.56
-7.66
-25.72
-48.50
-43.00
-16.08
Net Investments
-27.53
-120.03
-29.43
-17.35
0.01
-0.90
0.75
-0.05
-0.04
Others
16.68
-38.88
8.84
0.80
1.93
3.96
3.86
-2.39
-0.32
Cash from Financing Activity
79.77
89.79
-11.60
-6.74
-13.95
-8.67
-5.96
-1.48
-1.30
-0.37
Net Cash Inflow / Outflow
69.94
72.76
-14.13
24.76
22.73
18.55
9.99
-14.97
10.18
6.98
Opening Cash & Equivalents
150.65
77.17
91.31
66.55
45.37
26.82
16.84
31.80
21.62
14.64
Closing Cash & Equivalent
220.77
150.65
77.17
91.31
68.10
45.37
26.82
16.84
31.80
21.62

Financial Ratios

Consolidated /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Jun 15
Jun 14
Jun 13
Jun 12
Jun 11
Book Value (Rs.)
114.21
78.03
47.69
29.73
16.25
11.84
7.68
5.22
3.95
3.36
ROA
23.02%
28.41%
33.68%
30.54%
18.46%
20.12%
16.48%
11.59%
9.00%
8.84%
ROE
29.58%
37.14%
49.43%
54.97%
43.13%
55.78%
53.24%
40.49%
29.10%
24.90%
ROCE
33.46%
45.59%
64.08%
69.03%
55.41%
71.11%
68.99%
56.69%
34.62%
26.87%
Fixed Asset Turnover
2.76
2.58
2.53
2.14
1.48
1.89
2.00
2.73
2.61
2.04
Receivable days
82.19
80.37
53.72
18.62
10.40
4.17
1.00
11.66
26.30
37.63
Inventory Days
58.28
18.54
17.16
18.68
24.83
17.00
21.31
24.06
20.01
24.84
Payable days
28.33
65.76
89.68
88.17
103.48
69.75
79.69
85.60
79.07
88.42
Cash Conversion Cycle
112.15
33.15
-18.80
-50.88
-68.24
-48.58
-57.39
-49.89
-32.75
-25.95
Total Debt/Equity
0.04
0.00
0.00
0.00
0.02
0.02
0.06
0.12
0.23
0.38
Interest Cover
228.51
391.22
309.72
235.08
179.35
56.11
53.29
29.73
9.88
7.84

News Update:


  • Caplin Point Lab - Quarterly Results
    10th Aug 2020, 12:26 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.